SCHEMBL3514931

SCHEMBL3514931

O=c1c(-c2ccccc2)c(OS(=O)(=O)C(F)(F)F)c2cc(F)cnc2n1OCc1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.33
TSHR P16473 2/20 0.33
ALDH1A2 O94788 1/20 0.33
ALDH1A3 P47895 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CYP1A2 P05177 4/20 0.32
CASP1 P29466 4/20 0.32
CASP7 P55210 4/20 0.32
HSD17B10 Q99714 4/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
TACR1 P25103 1/20 0.31
MAPK14 Q16539 1/20 0.31
MAPT P10636 1/20 0.31
CYP3A4 P08684 3/20 0.30
CYP2C9 P11712 3/20 0.30
PTGS1 P23219 1/20 0.30
PTGS2 P35354 1/20 0.30
TP53 P04637 2/20 0.30
ARF6 P62330 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3516535 0.81 ALDH1A1 (0.38) ALDH1A1TSHRALDH1A2ALDH1A3L3MBTL1
SCHEMBL3515121 0.77 TAAR1 (0.36) ALDH1A1TSHRALDH1A2ALDH1A3L3MBTL1
SCHEMBL3519079 0.70 F2 (0.39) ALDH1A1MAPTHPGD
SCHEMBL3517053 0.69 MAPK8 (0.39) ALDH1A1TSHRCYP1A2CASP1CASP7
SCHEMBL16236700 0.69 MAPK8 (0.38) ALDH1A1TSHRHSD17B10MEN1KMT2A
SCHEMBL3519513 0.69 ALOX5 (0.38) ALDH1A1TSHR
SCHEMBL3544652 0.68 KDM4E (0.42) ALDH1A1TSHRMEN1KMT2AMAPT
SCHEMBL3515445 0.68 OPRM1 (0.35) ALDH1A1TSHRL3MBTL1MEN1KMT2A
SCHEMBL16275011 0.68 KDM4E (0.39) ALDH1A1TSHRL3MBTL1CASP1CASP7
SCHEMBL15585487 0.68 PTGS1 (0.40) ALDH1A1CYP1A2MEN1KMT2ATACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed
EP-2044068-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS Merck & Co., Inc. (US) 2009-04-08 EP disclosed
WO-2008010964-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK & CO., INC. (US) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS RNASEH1, RNASE1, RNASEL ALDH1A1 1486/4885TSHR 3624/4885ALDH1A2 2515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.